NASH Core Curriculum: Emerging Management

Hear expert perspectives on histologic and metabolic endpoints in NASH studies and how they may inform potential targets for oral, injectable, and combination NASH treatments.
Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC
Format: Microsoft PowerPoint (.ppt)
File Size: 2.72 MB
Released: July 20, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Gilead Sciences
Novo Nordisk Inc.

Related Content

Expert commentary on the use of diabetes technologies in pediatric patients, from Jennifer Sherr, MD, PhD, and Clinical Care Options (CCO)

Jennifer Sherr, MD, PhD Released: January 14, 2022

Listen to expert insights from Martin C. Mahoney, MD, PhD, on new data for vaccine-preventable diseases presented at the IDWeek meeting, including pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.

Martin C. Mahoney, MD, PhD Released: December 6, 2021

Clinical Care Options (CCO): Dr. Paul Auwaerter discusses the latest pneumococcal vaccine data and the impact on his practice, presented at IDWeek 2021

Paul G. Auwaerter, MD Released: November 19, 2021

Expert IDWeek 2021 video: vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza, from CCO

Martin C. Mahoney, MD, PhD Released: November 11, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings